Healthcare provider profile · identity verified

Emilija O Florance, MD

Family Practice · RANDOLPH, VT · NPI 1326434713

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	312	83
Losartan Potassium	Losartan Potassium	282	80
Lisinopril	Lisinopril	267	69
Metoprolol Succinate	Metoprolol Succinate	262	70
Levothyroxine Sodium	Levothyroxine Sodium	252	57
Gabapentin	Gabapentin	239	53
Amlodipine Besylate	Amlodipine Besylate	215	58
Omeprazole	Omeprazole	193	52
Simvastatin	Simvastatin	166	45
Metformin Hcl	Metformin Hcl	147	40
Rosuvastatin Calcium	Rosuvastatin Calcium	143	30
Albuterol Sulfate Hfa	Albuterol Sulfate	96	41
Eliquis	Apixaban	96	20
Pantoprazole Sodium	Pantoprazole Sodium	92	20
Sertraline Hcl	Sertraline Hcl	92	21
Citalopram Hbr	Citalopram Hydrobromide	91	16
Furosemide	Furosemide	84	28
Hydrochlorothiazide	Hydrochlorothiazide	84	24
Ozempic	Semaglutide	66	15
Potassium Chloride	Potassium Chloride	63	15
Bupropion Xl	Bupropion Hcl	61	15
Montelukast Sodium	Montelukast Sodium	61	14
Allopurinol	Allopurinol	58	12
Metformin Hcl Er	Metformin Hcl	57	13
Tamsulosin Hcl	Tamsulosin Hcl	54	15
Lovastatin	Lovastatin	53	13
Fluoxetine Hcl	Fluoxetine Hcl	52	13
Fluticasone Propionate	Fluticasone Propionate	52	18
Oxycodone Hcl	Oxycodone Hcl	52	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	52	14
Jardiance	Empagliflozin	51	13
Trazodone Hcl	Trazodone Hcl	51	11
Spironolactone	Spironolactone	50	14
Amitriptyline Hcl	Amitriptyline Hcl	44	12
Glipizide	Glipizide	42	suppressed
Nystatin	Nystatin	40	15
Zolpidem Tartrate	Zolpidem Tartrate	40	suppressed
Duloxetine Hcl	Duloxetine Hcl	36	suppressed
Pregabalin	Pregabalin	36	11
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Prednisone	Prednisone	34	23
Celecoxib	Celecoxib	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	24
Enalapril Maleate	Enalapril Maleate	31	suppressed
Famotidine	Famotidine	31	suppressed
Ventolin Hfa	Albuterol Sulfate	31	13
Carvedilol	Carvedilol	30	suppressed
Lidocaine	Lidocaine	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Tresiba Flextouch U-100	Insulin Degludec	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	12
Donepezil Hcl	Donepezil Hcl	28	suppressed
Glipizide Er	Glipizide	28	suppressed
Chlorthalidone	Chlorthalidone	26	12
Clonidine Hcl	Clonidine Hcl	26	suppressed
Ibuprofen	Ibuprofen	26	suppressed
Clonazepam	Clonazepam	25	suppressed
Meloxicam	Meloxicam	25	suppressed
Azithromycin	Azithromycin	24	13
Ketoconazole	Ketoconazole	23	12
Aripiprazole	Aripiprazole	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	21	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Atenolol	Atenolol	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Risperidone	Risperidone	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Baclofen	Baclofen	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Colchicine	Colchicine	15	suppressed
Nabumetone	Nabumetone	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Risedronate Sodium	Risedronate Sodium	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Phenobarbital	Phenobarbital	14	suppressed
Pramipexole Er	Pramipexole Di-Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Effexor Xr	Venlafaxine Hcl	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Finasteride	Finasteride	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Diazepam	Diazepam	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Nitroglycerin	Nitroglycerin	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error